Eva Oswald

714 total citations
39 papers, 493 citations indexed

About

Eva Oswald is a scholar working on Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eva Oswald has authored 39 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eva Oswald's work include Cancer Cells and Metastasis (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer Research and Treatments (6 papers). Eva Oswald is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer Research and Treatments (6 papers). Eva Oswald collaborates with scholars based in Germany, United Kingdom and United States. Eva Oswald's co-authors include Thilo Jakob, Stefan F. Martin, Axel Roers, László G. Puskás, Janka Zsófia Csepregi, Attila Mócsai, Tamás Németh, Felix Weber, Anne Dudeck and Béla Ózsvári and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eva Oswald

36 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Oswald Germany 12 187 110 74 68 66 39 493
Premkumar Vummidi Giridhar United States 8 106 0.6× 195 1.8× 192 2.6× 16 0.2× 23 0.3× 9 634
Jeng‐Wei Tjiu Taiwan 10 205 1.1× 176 1.6× 179 2.4× 15 0.2× 52 0.8× 25 590
Qingang Hu China 15 47 0.3× 116 1.1× 192 2.6× 45 0.7× 16 0.2× 37 555
Arancha Rodríguez‐Caballero Spain 15 401 2.1× 120 1.1× 139 1.9× 249 3.7× 17 0.3× 22 649
Giulia Pellizzari United Kingdom 8 143 0.8× 160 1.5× 253 3.4× 30 0.4× 6 0.1× 12 570
Pu Cheng China 17 195 1.0× 206 1.9× 253 3.4× 43 0.6× 17 0.3× 49 782
Marı́a L. Lamelas Spain 12 213 1.1× 319 2.9× 233 3.1× 43 0.6× 16 0.2× 16 751
Meagan E. Anderson United States 8 230 1.2× 89 0.8× 235 3.2× 13 0.2× 13 0.2× 8 634
Péter Balla Hungary 10 29 0.2× 68 0.6× 173 2.3× 35 0.5× 10 0.2× 15 379
Huilei Miao China 11 135 0.7× 176 1.6× 206 2.8× 16 0.2× 6 0.1× 39 535

Countries citing papers authored by Eva Oswald

Since Specialization
Citations

This map shows the geographic impact of Eva Oswald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Oswald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Oswald more than expected).

Fields of papers citing papers by Eva Oswald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Oswald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Oswald. The network helps show where Eva Oswald may publish in the future.

Co-authorship network of co-authors of Eva Oswald

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Oswald. A scholar is included among the top collaborators of Eva Oswald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Oswald. Eva Oswald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Redis, Roxana S., et al.. (2024). Abstract 2714: Developing an mRNA encoded therapeutic antibody platform to simplify manufacturing and reduce time to clinic. Cancer Research. 84(6_Supplement). 2714–2714.
2.
Oswald, Eva, Atay Vural, Vuslat Yılmaz, et al.. (2023). Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(2). 13 indexed citations
3.
Abbas, Amir, et al.. (2023). Initial Quenching Efficiency Determines Light‐Driven H2 Evolution of [Mo3S13]2− in Lipid Bilayers. Chemistry - A European Journal. 29(72). e202302284–e202302284. 3 indexed citations
4.
Oswald, Eva, Anne Grote, Nassim Bouteldja, et al.. (2022). Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-up. Journal for ImmunoTherapy of Cancer. 10(4). e004412–e004412. 10 indexed citations
5.
Oswald, Eva, et al.. (2022). Nanoscale surface modification via scanning electrochemical probe microscopy. Current Opinion in Electrochemistry. 34. 100965–100965. 16 indexed citations
6.
Oswald, Eva, et al.. (2022). Pd‐Modified De‐alloyed Au−Ni‐Microelectrodes for In Situ and Operando Mapping of Hydrogen Evolution. ChemElectroChem. 9(6). 9 indexed citations
7.
Zimmermann, Hanna, et al.. (2022). Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?. Multiple Sclerosis and Related Disorders. 67. 104175–104175. 4 indexed citations
8.
Oswald, Eva, Tobias Ullrich, Alexander K. Mengele, et al.. (2021). Cobaloxime Complex Salts: Synthesis, Patterning on Carbon Nanomembranes and Heterogeneous Hydrogen Evolution Studies. Chemistry - A European Journal. 27(68). 16896–16903. 23 indexed citations
9.
10.
Ateschrang, Atesch, U. Obertacke, Arndt‐Peter Schulz, et al.. (2021). Evidence-Based Examination Techniques for the Shoulder Joint. Zeitschrift für Orthopädie und Unfallchirurgie. 159(3). 332–335. 3 indexed citations
11.
Brock, Matthias, C. Heß, Eva Oswald, et al.. (2019). Abstract 1532: A novel, monovalent tri-specific antibody-based molecule that simultaneously modulates PD-L1 and 4-1BB exhibits potent anti-tumoral activity in vivo. Cancer Research. 79(13_Supplement). 1532–1532. 1 indexed citations
12.
Feuerhake, Friedrich, et al.. (2019). Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction. Oncotarget. 10(44). 4587–4597. 12 indexed citations
13.
Brock, Matthias, Alexandre Simonin, Eva Oswald, et al.. (2019). Abstract 1532: A novel, monovalent tri-specific antibody-based molecule that simultaneously modulates PD-L1 and 4-1BB exhibits potent anti-tumoral activityin vivo. Immunology. 1532–1532. 1 indexed citations
14.
Ahonen, Ilmari, Malin Åkerfelt, Mervi Toriseva, et al.. (2017). A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues. Scientific Reports. 7(1). 6600–6600. 14 indexed citations
15.
Davies, Emma Jane, Meng Dong, Matthias Gutekunst, et al.. (2015). Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices. Scientific Reports. 5(1). 17187–17187. 92 indexed citations
16.
Weber, Felix, Tamás Németh, Janka Zsófia Csepregi, et al.. (2014). Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. The Journal of Experimental Medicine. 212(1). 15–22. 131 indexed citations
17.
Sesărman, Alina, Eva Oswald, Mircea T. Chiriac, et al.. (2012). Why human pemphigoid autoantibodies do not trigger disease by the passive transfer into mice?. Immunology Letters. 143(1). 92–100. 11 indexed citations
18.
Oswald, Eva, Alina Sesărman, Claus-Werner Franzke, et al.. (2012). The Flavonoid Luteolin Inhibits Fcγ-Dependent Respiratory Burst in Granulocytes, but Not Skin Blistering in a New Model of Pemphigoid in Adult Mice. PLoS ONE. 7(2). e31066–e31066. 23 indexed citations
19.
Sesărman, Alina, et al.. (2010). Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII. Cellular and Molecular Life Sciences. 67(8). 1343–1351. 19 indexed citations
20.
Speckmann, Carsten, Anselm Enders, Cristina Woellner, et al.. (2008). Reduced memory B cells in patients with hyper IgE syndrome. Clinical Immunology. 129(3). 448–454. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Premkumar Vummidi Giridhar Breakdown of academic impact, for papers by Jeng‐Wei Tjiu Breakdown of academic impact, for papers by Qingang Hu Breakdown of academic impact, for papers by Arancha Rodríguez‐Caballero Breakdown of academic impact, for papers by Giulia Pellizzari Breakdown of academic impact, for papers by Pu Cheng Breakdown of academic impact, for papers by Marı́a L. Lamelas Breakdown of academic impact, for papers by Meagan E. Anderson Breakdown of academic impact, for papers by Péter Balla Breakdown of academic impact, for papers by Huilei Miao
Rankless by CCL
2026